Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.
Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe Locations section was expanded to include a comprehensive, multi-region list of study sites across US states, Canadian provinces, and other regions, replacing the prior listing.SummaryDifference2%
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor administrative update that does not affect study data or eligibility, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check39 days agoChange DetectedThe government funding status banner was removed from the page, removing a site-wide notice about potential delays in operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check61 days agoChange DetectedAdded UC Davis Medical Center in Sacramento, CA, increasing total locations to 90; the Last Update Posted field shows an estimated date.SummaryDifference1%
- Check83 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference4%
- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.